Search research articles
Contact Us
Filters
Showing results (61-70 of 183) with videos related to
Page
of 19
Sort By:
British Journal of Haematology
|
June 1, 1995
Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity?
P Mathew, G J Ahmann, T E Witzig, et al.
American Journal of Clinical Pathology
|
October 1, 1996
Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia
A Tefferi, B J Bartholmai, T E Witzig, et al.
Clinical Lymphoma
|
November 15, 2001
A randomized, placebo-controlled study of outpatient premedication for bone marrow biopsy in adults with lymphoma
A P Wolanskyj, G Schroeder, P R Wilson, et al.
British Journal of Haematology
|
June 1, 1996
Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells
S H Okuno, A Tefferi, C A Hanson, et al.
Cancer
|
September 15, 1995
S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma
T E Witzig, T M Habermann, P J Kurtin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis
M A Gertz, M Q Lacy, J A Lust, et al.
Blood
|
September 1, 1996
Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma
T E Witzig, M A Gertz, J A Lust, et al.
American Journal of Hematology
|
April 1, 1989
Detection of hypodiploidy using multi-parameter flow cytometric analysis: a prognostic indicator in multiple myeloma
R J Morgan, N J Gonchoroff, J A Katzmann, et al.
Leukemia
|
May 1, 1996
Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6
J J Westendorf, G J Ahmann, P R Greipp, et al.
Cancer
|
March 26, 1999
Osseous Hodgkin disease
M L Ostrowski, C Y Inwards, J G Strickler, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 183) with videos related to
Sort By:
Page
of 19
British Journal of Haematology
|
June 1, 1995
Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity?
P Mathew, G J Ahmann, T E Witzig, et al.
American Journal of Clinical Pathology
|
October 1, 1996
Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia
A Tefferi, B J Bartholmai, T E Witzig, et al.
Clinical Lymphoma
|
November 15, 2001
A randomized, placebo-controlled study of outpatient premedication for bone marrow biopsy in adults with lymphoma
A P Wolanskyj, G Schroeder, P R Wilson, et al.
British Journal of Haematology
|
June 1, 1996
Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells
S H Okuno, A Tefferi, C A Hanson, et al.
Cancer
|
September 15, 1995
S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma
T E Witzig, T M Habermann, P J Kurtin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis
M A Gertz, M Q Lacy, J A Lust, et al.
Blood
|
September 1, 1996
Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma
T E Witzig, M A Gertz, J A Lust, et al.
American Journal of Hematology
|
April 1, 1989
Detection of hypodiploidy using multi-parameter flow cytometric analysis: a prognostic indicator in multiple myeloma
R J Morgan, N J Gonchoroff, J A Katzmann, et al.
Leukemia
|
May 1, 1996
Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6
J J Westendorf, G J Ahmann, P R Greipp, et al.
Cancer
|
March 26, 1999
Osseous Hodgkin disease
M L Ostrowski, C Y Inwards, J G Strickler, et al.
Page
of 19